Primary Biliary Cholangitis (PBC): Highlights from EASL 2023 - Part 2

COR2ED - Rare Diseases Medical Conversation
06/12/2023 22 min
Primary Biliary Cholangitis (PBC): Highlights from EASL 2023 - Part 2

Listen " Primary Biliary Cholangitis (PBC): Highlights from EASL 2023 - Part 2 "

Descargar episodio Ver en sitio original

Episode Synopsis


Robert Mitchell-Thain, CEO of the PBC Foundation, Edinburgh, UK and Kath Houghton, Autoimmune Specialist Nurse, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK, discuss their ‘Primary Biliary Cholangitis (PBC) highlights from EASL 2023’ in this podcast.
Their discussion covers the relationship between initial symptoms and disease trajectory, the association of biochemical control and outcomes in PBC, and the impact and assessment of patient reported outcomes.

More episodes of the podcast COR2ED - Rare Diseases Medical Conversation

Understanding EP-NEC: Through Diagnosis, Treatment, and Support 07/11/2025
Exploring the role of targeted radiopharmaceutical treatment in NETs 30/09/2025
Short-stature conditions, including SPIGFD 10/12/2024
Neuroendocrine tumours (NETs) – Shared decision-making. Part 2: Individualising treatment decisions 11/09/2024
Neuroendocrine tumours (NETs) – Shared decision-making. Part 1: Patient journey 11/09/2024
Regional differences in NET: Treatment and future developments 28/05/2024
Regional differences in NET: Epidemiology, diagnosis, and referral strategies 28/05/2024
Short stature: Severe primary IGF-I deficiency (SPIGFD). Part 2 12/12/2023
Short stature: Key challenges in diagnosis and management. Part 1 06/12/2023
Gene therapy and gene-modified cell therapy in rare diseases 06/12/2023
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA